<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijms-21-09653-t008" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijms-21-09653-t008_Table 8</object-id>
 <label>Table 8</label>
 <caption>
  <p>Beneficial effects of 
   <italic>Origanum vulgare</italic> L. essential oil (OEO) on skin disorders.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Types of Skin Disorders</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Details: Source, Phytochemical Composition; Dose, Formulation</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effects</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Acne vulgaris</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">OEO was received from Nebraska University, Lincoln, NE, USA
     <break/>GS-MS assay determined the main phytocompounds:
     <break/>thymol (99.44%), 
     <break/>
     <italic>p</italic>-cymene (0.2%), 
     <break/>cineole (0.06%)
     <break/>OEO was formulated as nanoemulsion 5%(
     <italic>w</italic>/
     <italic>w</italic>) mixture of OEO and Pluronic F127
     <break/>Nanoemulsion was tested in an acne animal mouse model (45 BALB/c, 6 weeks old, 20 g of weight) intradermally injected in ears with 20 µL of 
     <italic>Propionibacterium acnes</italic>.
     <break/>They applied on infected mice ears, 20 µL of 2 MIC (1.34 mg/mL) oregano formulated nanoemulsion (test group), or 2% erythromycin (positive control), or no treatment (negative control) for 3 days.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Mice treated with nanoemulsion presented a higher anti-inflammatory response (&gt;60%) compared to the positive control erythromycin (20%)
     <break/>The in vivo antimicrobial activity of OEO nanoemulsion was assessed where bacterial
     <break/>counts of 
     <italic>Propionibacterium acnes</italic> dropped from 1 × 10
     <sup>8</sup> to 4.3 × 10
     <sup>1</sup> CFU (colony forming units)/mL post-treatment with 0.672 mg/mL of oregano nanoemulsion. 
     <break/>-Histopathological and
     <break/>digital photography of infected mice ears treated revealed normal histology of mouse ear tissue with the absence of inflammatory reaction.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B39-ijms-21-09653" ref-type="bibr">39</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" colspan="1">Wound and anti-inflammatory potential</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">OEO was provided by Esperis S.p.A., Milan, Italy.
     <break/>The qualitative and quantitative characterization of OEO was assessed by GC and GC-MS. The main
     <break/>components were:
     <break/>carvacrol (35.95 + 0.22%),
     <break/>thymol (25.2 + 0.27%), 
     <break/>
     <italic>p</italic>-cymene (21.54 + 0.35%), 
     <break/>linalool (4.26 + 0.05%).
     <break/>Different concentrations of OEO (3, 5, 7.5, 10, 12, 25, and 50 μg/mL were tested but 25 μg/mL concentration was used as a standard for all experiments.
     <break/>Antioxidant activity was evaluated in NCTC 2544 cells line measuring the 2′,7′ oxidation dichlorodihydrofluorescein diacetate and the incubation time was 72 h
     <break/>Analysis regarding the amount of mRNA and proteins of ICAM-1, iNOS, and COX-2 were assessed by RT-PCR and Western blot
     <break/>PCNA modulation was evaluated by immunoblot
     <break/>human keratinocyte cell line NCTC 2544 was used as an inflammatory in vitro model.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">reduction and/or modulation of the inflammatory parameters: 
     <break/>ROS(reactive oxygen species),
     <break/>ICAM-1(intracellular cell adhesion molecule 1)
     <break/>-iNOS(inducible nitric oxidesynthase)
     <break/>-COX
     <sub>2</sub>
     <break/>MMP-1 (matrix metalloproteinase 1)and MMP-12
     <break/>PCNA(proliferating cell nuclear antigen)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B73-ijms-21-09653" ref-type="bibr">73</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">OEO was provided by doTERRA, Pleasant Grove, UT, USA
     <break/>Phytochemical constituents were not mentioned
     <break/>Dermal fibroblast system was designed to model chronic inflammation and fibrosis (BioMAP HDF3CGF)
     <break/>Cell proliferation and viability of four concentrations of OEO (0.011, 0.0037, 0.0012, and 0.00041%, 
     <italic>v/v</italic>) were measured using a sulforhodamine B assay
     <break/>The potential anti-inflammatory and tissue remodelling properties of the OEO were tested via ELISA method.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">The research group showed that the concentration (0.011% 
     <italic>v/v</italic>) was cytotoxic
     <break/>Results showed a significant antiproliferative activity to dermal fibroblast cells. OEO (0,0037% 
     <italic>v/v</italic> OEO) significantly decreased the levels of inflammatory biomarkers such as MCP-1 (monocyte chemoattractant protein 1), VCAM-1 (vascular cell adhesion molecule 1), ICAM-1 (intracellular cell adhesion molecule 1), IP-10 (Interferon gamma-induced protein 10), I-TAC (interferon-inducible T-cell alpha chemoattractant), and MIG (monokine induced by gamma interferon). Moreover, OEO diminished tissue remodelling biomarkers such as collagen I, collagen III, M-CSF (macrophage colony-stimulating factor), EGRF (epidermal growth factor receptor), MMP-1, PAI-1, TIMP-1 (tissue inhibitor of metalloproteinase-1), and TIMP- 2. 
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B74-ijms-21-09653" ref-type="bibr">74</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin aging</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole plants of 
     <italic>Origanum vulgare</italic> L. were harvested from Chiang Mai, Thailand
     <break/>Commercial OEO was obtained from Botanicessence (Product
     <break/>of Spain). 
     <break/>GS-MS chromatograms noted carvacrol, 
     <italic>m</italic>-thymol, 
     <italic>p</italic>-cymene, and 
     <italic>γ</italic>-terpinene as major chemical constituents in both oils.
     <break/>For the determination of anti-collagenase, anti-elastase activity, anti-hyaluronidase activity were used ascorbic acid and oleanolic acid as positive controls.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OEO obtained from a tropical area in Thailand had greater anti-skin-aging activity than ascorbic acid (
     <italic>p</italic> &lt; 0.01), and the inhibitory activities against collagenase, elastase, and hyaluronidase were 92.0 ± 9.7%, 53.1 ± 13.3%, and 16.7 ± 0.3%, at the concentration of 67, 25, and 4 µg/mL, respectively.
     <break/>The anti-hyaluronidase activity of both essential oils (commercial OEO-15.5% and OEO from Chiang Mai-16.7%) was more mitigated than the one of oleanolic acid (86%).
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B63-ijms-21-09653" ref-type="bibr">63</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
